• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Patients with Nonalcoholic Fatty Liver Disease (NAFLD) have Higher Oxidative Stress in Comparison to Chronic Viral Hepatitis.与慢性病毒性肝炎相比,非酒精性脂肪性肝病(NAFLD)患者具有更高的氧化应激水平。
J Clin Exp Hepatol. 2013 Mar;3(1):12-8. doi: 10.1016/j.jceh.2012.10.009. Epub 2012 Nov 2.
2
Mechanism of the development of nonalcoholic steatohepatitis after pancreaticoduodenectomy.胰十二指肠切除术后非酒精性脂肪性肝炎的发生机制
BBA Clin. 2015 Feb 19;3:168-74. doi: 10.1016/j.bbacli.2015.02.001. eCollection 2015 Jun.
3
Effect of Korean Red Ginseng on metabolic syndrome.韩国红参对代谢综合征的影响。
J Ginseng Res. 2021 May;45(3):380-389. doi: 10.1016/j.jgr.2020.11.002. Epub 2020 Nov 12.
4
Prevalence of steatosis and insulin resistance in patients with chronic hepatitis B compared with chronic hepatitis C and non-alcoholic fatty liver disease.慢性乙型肝炎患者与慢性丙型肝炎患者及非酒精性脂肪性肝病患者相比,脂肪变性和胰岛素抵抗的患病率
Eur J Intern Med. 2015 Jan;26(1):30-6. doi: 10.1016/j.ejim.2014.12.001. Epub 2014 Dec 29.
5
Monascin and ankaflavin act as natural AMPK activators with PPARα agonist activity to down-regulate nonalcoholic steatohepatitis in high-fat diet-fed C57BL/6 mice.虾青素和安卡黄素作为天然 AMPK 激活剂,具有 PPARα 激动剂活性,可下调高脂饮食喂养的 C57BL/6 小鼠的非酒精性脂肪性肝炎。
Food Chem Toxicol. 2014 Feb;64:94-103. doi: 10.1016/j.fct.2013.11.015. Epub 2013 Nov 22.
6
Role of oxidative stress and insulin resistance in disease severity of non-alcoholic fatty liver disease.氧化应激和胰岛素抵抗在非酒精性脂肪性肝病疾病严重程度中的作用。
Turk J Gastroenterol. 2016 Jul;27(4):361-6. doi: 10.5152/tjg.2016.16106.
7
Status of essential trace minerals and oxidative stress in viral hepatitis C patients with nonalcoholic fatty liver disease.丙型肝炎病毒患者合并非酒精性脂肪性肝病时必需微量元素和氧化应激状态。
Int J Med Sci. 2013 Apr 17;10(6):730-7. doi: 10.7150/ijms.6104. Print 2013.
8
[Investigation of oxidative stress and antioxidant defense in patients with hepatitis B virus infection and the effect of interferon-alpha plus lamivudine combination therapy on oxidative stress].[乙型肝炎病毒感染患者氧化应激与抗氧化防御的研究及α-干扰素联合拉米夫定治疗对氧化应激的影响]
Mikrobiyol Bul. 2009 Jul;43(3):411-23.
9
Oxidant stress and antioxidant status among patients with nonalcoholic fatty liver disease (NAFLD).非酒精性脂肪性肝病(NAFLD)患者的氧化应激与抗氧化状态
J Clin Gastroenterol. 2006 Nov-Dec;40(10):930-5. doi: 10.1097/01.mcg.0000212608.59090.08.
10
Gegen Qinlian Decoction Ameliorates Nonalcoholic Fatty Liver Disease in Rats Oxidative Stress, Inflammation, and the NLRP3 Signal Axis.葛根芩连汤通过氧化应激、炎症和NLRP3信号轴改善大鼠非酒精性脂肪性肝病
Evid Based Complement Alternat Med. 2021 Feb 16;2021:6659445. doi: 10.1155/2021/6659445. eCollection 2021.

引用本文的文献

1
Exogenous HS reduces oxidative stress induced by lipid mixture in HepG2 cells through USP22/SIRT1 axis.外源性透明质酸通过USP22/SIRT1轴减轻脂质混合物在HepG2细胞中诱导的氧化应激。
Sci Rep. 2025 Jul 2;15(1):23129. doi: 10.1038/s41598-025-04924-2.
2
Mechanistic Elucidation of Polysaccharides in Treating MAFLD via Regulation of the Gut Microbiota-Metabolite-Ferroptosis Axis: A Multi-Omics Perspective.基于多组学视角解析多糖通过调节肠道微生物群-代谢物-铁死亡轴治疗MAFLD的机制
J Agric Food Chem. 2025 Jun 26. doi: 10.1021/acs.jafc.5c05877.
3
From Childhood Obesity to Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) and Hyperlipidemia Through Oxidative Stress During Childhood.从儿童肥胖到儿童期氧化应激导致的代谢功能障碍相关脂肪性肝病(MASLD)和高脂血症。
Metabolites. 2025 Apr 24;15(5):287. doi: 10.3390/metabo15050287.
4
Elevated serum neprilysin levels in patients with chronic hepatitis C and metabolic dysfunction-associated steatotic liver disease: hepatic oxidative stress as an underlying mechanism.慢性丙型肝炎和代谢功能障碍相关脂肪性肝病患者血清中性肽链内切酶水平升高:肝脏氧化应激作为潜在机制
Mol Biol Rep. 2024 Dec 26;52(1):81. doi: 10.1007/s11033-024-10152-0.
5
Downregulation of the MARC1 p.A165 risk allele reduces hepatocyte lipid content by increasing beta-oxidation.MARC1基因p.A165风险等位基因的下调通过增加β-氧化作用降低肝细胞脂质含量。
Clin Mol Hepatol. 2025 Apr;31(2):445-459. doi: 10.3350/cmh.2024.0642. Epub 2024 Dec 23.
6
Metabolic dysfunction-associated steatotic liver disease-induced changes in the antioxidant system: a review.代谢功能障碍相关脂肪性肝病引起的抗氧化系统变化:综述
Arch Toxicol. 2025 Jan;99(1):1-22. doi: 10.1007/s00204-024-03889-x. Epub 2024 Oct 23.
7
A Novel Antioxidant, Hydrogen-Rich Coral Calcium Alters Gut Microbiome and Bile Acid Synthesis to Improve Methionine-and-Choline-Deficient Diet-Induced Non-Alcoholic Fatty Liver Disease.一种新型抗氧化剂——富氢珊瑚钙可改变肠道微生物群和胆汁酸合成,以改善蛋氨酸和胆碱缺乏饮食诱导的非酒精性脂肪性肝病。
Antioxidants (Basel). 2024 Jun 20;13(6):746. doi: 10.3390/antiox13060746.
8
Oxidative Stress as a Target for Non-Pharmacological Intervention in MAFLD: Could There Be a Role for EVOO?氧化应激作为非酒精性脂肪性肝病非药物干预的靶点:特级初榨橄榄油能发挥作用吗?
Antioxidants (Basel). 2024 Jun 16;13(6):731. doi: 10.3390/antiox13060731.
9
A Prospective Randomised Comparative Four-arm Intervention Study of Efficacy and Safety of Saroglitazar and Vitamin E in Patients With Non-alcoholic Fatty Liver Disease (NAFLD)/Non-alcoholic Steatohepatitis (NASH)-SVIN TRIAL.一项关于沙罗格列他与维生素E治疗非酒精性脂肪性肝病(NAFLD)/非酒精性脂肪性肝炎(NASH)疗效和安全性的前瞻性随机对照四臂干预研究——SVIN试验
J Clin Exp Hepatol. 2024 Sep-Oct;14(5):101398. doi: 10.1016/j.jceh.2024.101398. Epub 2024 Mar 18.
10
Extracellular Superoxide Dismutase Attenuates Hepatic Oxidative Stress in Nonalcoholic Fatty Liver Disease through the Adenosine Monophosphate-Activated Protein Kinase Activation.细胞外超氧化物歧化酶通过激活单磷酸腺苷激活蛋白激酶减轻非酒精性脂肪性肝病中的肝脏氧化应激。
Antioxidants (Basel). 2023 Nov 24;12(12):2040. doi: 10.3390/antiox12122040.

本文引用的文献

1
Nonalcoholic fatty liver in a developing country is responsible for significant liver disease.在一个发展中国家,非酒精性脂肪肝是导致严重肝脏疾病的原因。
Hepatology. 2010 Dec;52(6):2248-9. doi: 10.1002/hep.23838. Epub 2010 Jul 29.
2
Oxidative stress is independently associated with non-alcoholic fatty liver disease (NAFLD) in subjects with and without type 2 diabetes.氧化应激与 2 型糖尿病患者和非 2 型糖尿病患者的非酒精性脂肪性肝病(NAFLD)独立相关。
Clin Biochem. 2010 Jul;43(10-11):815-21. doi: 10.1016/j.clinbiochem.2010.04.003. Epub 2010 Apr 14.
3
Chronic acetonemia alters liver oxidative balance and lipid content in rats. A model of NASH?慢性丙酮血症会改变大鼠肝脏的氧化平衡和脂质含量。非酒精性脂肪性肝炎模型?
Exp Clin Endocrinol Diabetes. 2010 Jan;118(1):61-3. doi: 10.1055/s-0029-1225649. Epub 2009 Oct 23.
4
Blood oxidative stress markers in non-alcoholic steatohepatitis and how it correlates with diet.非酒精性脂肪性肝炎中的血液氧化应激标志物及其与饮食的相关性。
Scand J Gastroenterol. 2008 Jan;43(1):95-102. doi: 10.1080/00365520701559003.
5
Evaluation of blood oxidative stress-related parameters in alcoholic liver disease and non-alcoholic fatty liver disease.酒精性肝病和非酒精性脂肪性肝病中血液氧化应激相关参数的评估。
Scand J Clin Lab Invest. 2008;68(4):323-34. doi: 10.1080/00365510701673383.
6
Non-alcoholic fatty liver disease: the mist gradually clears.非酒精性脂肪性肝病:迷雾渐散。
J Hepatol. 2008;48 Suppl 1:S104-12. doi: 10.1016/j.jhep.2008.01.009. Epub 2008 Feb 4.
7
Insulin tolerance test is comparable to homeostasis model assessment for insulin resistance in patients with nonalcoholic fatty liver disease.对于非酒精性脂肪性肝病患者,胰岛素耐量试验与胰岛素抵抗的稳态模型评估具有可比性。
Indian J Gastroenterol. 2007 Jul-Aug;26(4):170-3.
8
The clinicopathological profile of Indian patients with nonalcoholic fatty liver disease (NAFLD) is different from that in the West.印度非酒精性脂肪性肝病(NAFLD)患者的临床病理特征与西方患者不同。
Dig Dis Sci. 2007 Sep;52(9):2368-74. doi: 10.1007/s10620-006-9136-y. Epub 2007 Apr 10.
9
Indian patients with nonalcoholic fatty liver disease presenting with raised transaminases are different at presentation.转氨酶升高的非酒精性脂肪性肝病印度患者在就诊时存在差异。
World J Gastroenterol. 2007 Jan 28;13(4):649-50. doi: 10.3748/wjg.v13.i4.649.
10
Oxidant stress and antioxidant status among patients with nonalcoholic fatty liver disease (NAFLD).非酒精性脂肪性肝病(NAFLD)患者的氧化应激与抗氧化状态
J Clin Gastroenterol. 2006 Nov-Dec;40(10):930-5. doi: 10.1097/01.mcg.0000212608.59090.08.

与慢性病毒性肝炎相比,非酒精性脂肪性肝病(NAFLD)患者具有更高的氧化应激水平。

Patients with Nonalcoholic Fatty Liver Disease (NAFLD) have Higher Oxidative Stress in Comparison to Chronic Viral Hepatitis.

作者信息

Kumar Amit, Sharma Arun, Duseja Ajay, Das Ashim, Dhiman Radha K, Chawla Yogesh K, Kohli Krishan K, Bhansali Anil

机构信息

Department of Hepatology, Postgraduate Institute of Medical Education and Research, Sector 12, Chandigarh 160012, India.

Department of Histopathology, Postgraduate Institute of Medical Education and Research, Sector 12, Chandigarh 160012, India.

出版信息

J Clin Exp Hepatol. 2013 Mar;3(1):12-8. doi: 10.1016/j.jceh.2012.10.009. Epub 2012 Nov 2.

DOI:10.1016/j.jceh.2012.10.009
PMID:25755466
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3940559/
Abstract

INTRODUCTION

Oxidative stress and cytokines play an important role in the pathogenesis of nonalcoholic fatty liver disease (NAFLD). We compared the presence of oxidative stress and cytokines in 25 patients with NAFLD with 25 age, sex and BMI-matched patients with chronic viral hepatitis (CVH) and 25 healthy volunteers (HV).

METHODOLOGY

Oxidative stress was studied biochemically by markers of lipid peroxidation and biochemical assessment of anti-oxidant status and various cytokines were studied by ELISA.

RESULTS

Patients with NAFLD had significantly higher levels of malondialdehyde (MDA) (p = 0.000) and conjugated dienes (CD) (p = 0.000) in comparison to HVs. Patients with NAFLD also had significantly higher MDA levels (p = 0.000) in comparison to CVH patients. Patients with NAFLD had significantly lower GSH levels (p = 0.004) in comparison to HVs. Patients with NAFLD had higher GPx activity (p = 0.028) in comparison to HVs. Catalase activity was significantly decreased in both NAFLD (p = 0.001) and CVH patients (p = 0.000) in comparison to HVs. Patients with NAFLD had significantly higher SOD activity (p = 0.000) in comparison to CVH patients. There was no difference in serum levels of IL-1β and TNF-α amongst three groups. Patients with CVH were found to have higher IL-8 serum levels (p = 0.039) in comparison to HVs. CVH patients also had higher TGF-β levels (p = 0.002) in comparison to both NAFLD patients and HVs.

CONCLUSION

Differences in the markers of oxidative stress and anti-oxidant status between NAFLD, CVH and healthy volunteers suggest presence of higher oxidative stress in patients with NAFLD.

摘要

引言

氧化应激和细胞因子在非酒精性脂肪性肝病(NAFLD)的发病机制中起重要作用。我们比较了25例NAFLD患者与25例年龄、性别和体重指数(BMI)匹配的慢性病毒性肝炎(CVH)患者以及25名健康志愿者(HV)体内氧化应激和细胞因子的情况。

方法

通过脂质过氧化标志物进行氧化应激的生化研究,并对抗氧化状态进行生化评估,通过酶联免疫吸附测定法(ELISA)研究各种细胞因子。

结果

与健康志愿者相比,NAFLD患者的丙二醛(MDA)水平(p = 0.000)和共轭二烯(CD)水平(p = 0.000)显著更高。与CVH患者相比,NAFLD患者的MDA水平也显著更高(p = 0.000)。与健康志愿者相比,NAFLD患者的谷胱甘肽(GSH)水平显著更低(p = 0.004)。与健康志愿者相比,NAFLD患者的谷胱甘肽过氧化物酶(GPx)活性更高(p = 0.028)。与健康志愿者相比,NAFLD患者(p = 0.001)和CVH患者(p = 0.000)的过氧化氢酶活性均显著降低。与CVH患者相比,NAFLD患者的超氧化物歧化酶(SOD)活性显著更高(p = 0.000)。三组之间白细胞介素-1β(IL-1β)和肿瘤坏死因子-α(TNF-α)的血清水平没有差异。与健康志愿者相比,CVH患者的IL-8血清水平更高(p = 0.039)。与NAFLD患者和健康志愿者相比,CVH患者的转化生长因子-β(TGF-β)水平也更高(p = 0.002)。

结论

NAFLD、CVH和健康志愿者之间氧化应激和抗氧化状态标志物的差异表明,NAFLD患者存在更高的氧化应激。